Kidney dysfunction induced by a hyperpalatable diet: Role of sodium/glucose Co-transporter inhibition in male mice
European Journal of Pharmacology · 2025
DOI: 10.1016/j.ejphar.2025.178024 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2025. Verfasst von Mariana Coelho Moraes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, 31270-901, Brazil; Department o…. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Benzhydryl Compounds, Glucosides, Kidney. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de Minas Gerais.
Abstract (Originalsprache)
Obesity-related kidney disease (ORKD) is a progressive kidney disease secondary to obesity, in which lipid deposition in proximal tubule epithelial cells drives tubular damage and inflammation. Considering that sodium/glucose co-transporter 2 (SGLT2) inhibitors are known to modulate renal lipid metabolism, we investigated the effect of SGLT2 inhibition on the development of hyperpalatable diet-induced ORKD. Obesity was induced in male and female C57Bl/6 mice through the administration of a high sugar and butter diet (HSB diet) for 12 weeks. Both sexes exhibited increased body weight and adiposity in response to the HSB diet; however, only male mice developed significant renal and metabolic alterations. In males, the HSB diet induced: (1) fasting hyperglycemia and impaired glucose tolerance; (2) increased renal triglyceride levels; (3) reduced creatinine clearance (CCr), a surrogate marker of glomerular filtration rate (eGFR), and altered fluid balance; (4) tubular proteinuria; (5) histological evidence of tubular injury; and (6) elevated renal pro-inflammatory cytokine levels and tubulointerstitial cell infiltration. When indicated, mice were treated daily with 1 mg/kg of dapagliflozin (DAPA), an SGLT2 inhibitor, for 4 weeks. DAPA treatment effectively attenuated the renal and metabolic alterations induced by the HSB diet in male mice. These findings suggest that, in male mice, hyperpalatable diet-induced ORKD involves SGLT2-dependent renal lipid accumulation, which may contribute to tubular proteinuria, injury, and inflammation. This study provides new insights into the molecular mechanisms underlying ORKD and supports the therapeutic potential of SGLT2 inhibitors for its prevention or treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, 31270-901, Brazil; Department of Physiology and Biophysics, Institute of Biological Sciences, Federal…
- Department of Physiology and Biophysics, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, 31270-901, Brazil.
- Department of Pharmacology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, 31270-901, Brazil.
- Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, 31270-901, Brazil.
- Department of Pharmacology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, 31270-901, Brazil. Electronic address: lubvieira@icb.ufmg.br.
- Department of Physiology and Biophysics, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, 31270-901, Brazil. Electronic address: dperuchetti@ufmg.br.
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Foundation for Research Development
- Universidade Federal de Minas Gerais
Zitieren
APA
Moraes, M. C., Oliveira, L. B. F., Campos, M. R., Barahuna-Filho, P. F. R., Cardozo, P. L., Vieira, M. A. R., Ribeiro, F. M., Vieira, L. B., & Peruchetti, D. B. (2025). Kidney dysfunction induced by a hyperpalatable diet: Role of sodium/glucose Co-transporter inhibition in male mice. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.178024
Vancouver
Moraes MC, Oliveira LBF, Campos MR, Barahuna-Filho PFR, Cardozo PL, Vieira MAR, et al. Kidney dysfunction induced by a hyperpalatable diet: Role of sodium/glucose Co-transporter inhibition in male mice. European Journal of Pharmacology. 2025. doi:10.1016/j.ejphar.2025.178024
BibTeX
@article{Moraes2025,
author = {Moraes, Mariana Coelho and Oliveira, Laura Barroso Ferreira and Campos, Mariana Rodrigues and Barahuna-Filho, Paulo Francisco Reis and Cardozo, Pablo Leal and Vieira, Maria Aparecida Ribeiro and Ribeiro, Fabiola Mara and Vieira, Luciene Bruno and Peruchetti, Diogo Barros},
title = {Kidney dysfunction induced by a hyperpalatable diet: Role of sodium/glucose Co-transporter inhibition in male mice},
journal = {European Journal of Pharmacology},
year = {2025},
doi = {10.1016/j.ejphar.2025.178024}
}
EUVIMED